Pioglitazone: Interim data

In a placebo-controlled, double-blind study in 55 evaluable NASH patients, pioglitazone led to metabolic

Read the full 140 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE